Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.

× No keyword cloud information.

52 in total

1. Secondary rhegmatogenous retinal detachment following intravitreal bevacizumab in patients with vitreous hemorrhage or tractional retinal detachment secondary to Eales' disease.

Authors: Atul Kumar; Sri Vatsa Sehra; M B Thirumalesh; Varun Gogia
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-12-15 Impact factor: 3.117

2. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.

Authors: Dong Ho Park; Jae Pil Shin; Si Yeol Kim
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-12-12 Impact factor: 3.117

3. Bevacizumab prior to vitrectomy for diabetic traction retinal detachment.

Authors: R Pokroy; U R Desai; E Du; Y Li; P Edwards
Journal: Eye (Lond) Date: 2011-07-08 Impact factor: 3.775

Review 4. A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors: P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal: Eye (Lond) Date: 2014-02-14 Impact factor: 3.775

5. Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.

Authors: Farzin Forooghian; Peter J Kertes; Kenneth T Eng; Elvira Agrón; Emily Y Chew
Journal: Invest Ophthalmol Vis Sci Date: 2009-12-10 Impact factor: 4.799

6. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).

Authors: Stanislao Rizzo; Federica Genovesi-Ebert; Emanuele Di Bartolo; Andrea Vento; Sofia Miniaci; George Williams
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-02-20 Impact factor: 3.117

7. Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors: Louis K Chang; David Sarraf
Journal: Clin Ophthalmol Date: 2008-06

8. Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy.

Authors: Ashraf M El-Batarny
Journal: Clin Ophthalmol Date: 2008-12

9. Intravitreal bevacizumab: an analysis of the evidence.

Authors: Derrick P Smit; David Meyer
Journal: Clin Ophthalmol Date: 2007-09

10. Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation.

Authors: Sadri Chahed; Aurélie S Leroyer; Mounir Benzerroug; David Gaucher; Adriana Georgescu; Serge Picaud; Jean-Sébastien Silvestre; Alain Gaudric; Alain Tedgui; Pascale Massin; Chantal M Boulanger
Journal: Diabetes Date: 2009-12-15 Impact factor: 9.461